Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
$2.3M Sell
29,998
-2,600
-8% -$207K 1.35% 29
2021
Q3
$2.45M Hold
32,598
1.45% 25
2021
Q2
$2.54M Sell
32,598
-1,565
-5% -$116K 1.49% 25
2021
Q1
$2.51M Hold
34,163
1.54% 25
2020
Q4
$2.67M Hold
34,163
1.75% 18
2020
Q3
$2.7M Sell
34,163
-270
-0.8% -$21.1K 1.95% 14
2020
Q2
$2.54M Sell
34,433
-1,260
-4% -$94.9K 1.96% 12
2020
Q1
$2.62M Hold
35,693
2.47% 9
2019
Q4
$3.1M Sell
35,693
-838
-2% -$68.8K 2.35% 10
2019
Q3
$2.93M Hold
36,531
2.28% 11
2019
Q2
$2.92M Sell
36,531
-246
-0.7% -$18.8K 2.23% 10
2019
Q1
$2.92M Hold
36,777
2.22% 10
2018
Q4
$2.68M Buy
+36,777
New +$2.6M 2.28% 9

Other funds holding MRK

Truehand Inc's MRK Position: Q4 2021 in Review

Truehand Inc reduced its Merck (MRK) stake by 8% in Q4 2021, selling an estimated $207K and leaving 29,998 shares worth $2.3M. The position accounts for 1.35% of the portfolio, ranked #29.

Truehand Inc first reported a position in MRK in Q4 2018 and has held it in 13 quarters since. The position peaked at $3.1M in Q4 2019. 2,902 funds tracked by Wall St. Rank hold MRK as of Q4 2021.

  • Truehand Inc held 29,998 shares of Merck worth $2.3M as of Q4 2021.
  • Truehand Inc sold 2,600 Merck shares in Q4 2021, an estimated $207K.
  • Merck made up 1.35% of Truehand Inc's portfolio in Q4 2021, its #29 holding.
  • Truehand Inc first reported a position in Merck in Q4 2018 and has held it in 13 quarters since.
  • Truehand Inc's Merck position peaked at $3.1M in Q4 2019.
  • 2,902 funds tracked by Wall St. Rank held Merck as of Q4 2021.

Based on Truehand Inc's 13F filing for Q4 2021, filed 9 Feb 2022.